This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Ovarian Cancer
  • /
  • Rucaparib: a novel PARP inhibitor for BRCA advance...

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

Read time: 1 mins
Published:21st Mar 2018
Author: Colombo I, Lheureux S, Oza AM.
Availability: Free full text
Ref.:Drug Des Devel Ther. 2018;12:605-617.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest